{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:00:46Z","timestamp":1776099646215,"version":"3.50.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the Kunming Health Science and Technology Talent Project - 10 Projects of China","award":["2023-SW (GUIDE)-07"],"award-info":[{"award-number":["2023-SW (GUIDE)-07"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,27]]},"abstract":"<jats:p>\n                    Lupus nephritis (LN) is a serious complication that adversely affects the prognosis of children with systemic lupus erythematosus. However, short-term prognostic indicators for LN in this population remain unclear. This retrospective cohort study aimed to identify factors associated with treatment remission in Chinese children with LN, with a focus on inflammatory markers. We included 72 children aged 0 to 18 years diagnosed with LN at our center between January 2022 and December 2024. Partial remission was defined as a \u226550% reduction from baseline in proteinuria and to an absolute value of &lt;3.0\u2009g\/g (300\u2009mg\/mmol), measured as the protein-to-creatinine ratio from a 24-hour urine collection, accompanied by stabilization or improvement in kidney function (estimated glomerular filtration rate, eGFR, within \u00b110% to 15% of baseline). The non-remission group comprised patients who failed to meet the above partial remission criteria within the 8 to 24 week follow-up period. Both univariate and multivariate Cox regression analyses revealed that elevated C-reactive protein (CRP) levels were significantly associated with failure to achieve remission (univariate hazard ratio 1.067, 95% CI: 1.011\u20131.126,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.019; multivariate hazard ratio 1.075, 95% CI: 1.019\u20131.134,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.008). A nomogram incorporating CRP demonstrated moderate discriminatory capacity for remission status at 24 weeks (AUC\u2005=\u20050.739). These findings indicate that baseline CRP is an independent risk factor for short-term remission failure in pediatric LN, suggesting that its monitoring may be beneficial for guiding clinical interventions. In conclusion, elevated CRP is an independent risk factor for short-term remission failure, and its monitoring may be beneficial for assessing treatment outcome.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047593","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T01:01:17Z","timestamp":1772240477000},"page":"e47593","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Elevated C-reactive protein and failure to achieve remission in pediatric lupus nephritis: A retrospective cohort study"],"prefix":"10.1097","volume":"105","author":[{"given":"Jia","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Nephrology & Rheumatology, Kunming Children\u2019s Hospital (Affiliated to Kunming Medical University), Kunming, Yunnan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongye","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology & Rheumatology, Kunming Children\u2019s Hospital (Affiliated to Kunming Medical University), Kunming, Yunnan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Nephrology & Rheumatology, Kunming Children\u2019s Hospital (Affiliated to Kunming Medical University), Kunming, Yunnan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yabin","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Nephrology & Rheumatology, Kunming Children\u2019s Hospital (Affiliated to Kunming Medical University), Kunming, Yunnan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology & Rheumatology, Kunming Children\u2019s Hospital (Affiliated to Kunming Medical University), Kunming, Yunnan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology & Rheumatology, Kunming Children\u2019s Hospital (Affiliated to Kunming Medical University), Kunming, Yunnan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2493-4732","authenticated-orcid":false,"given":"Bo","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Nephrology & Rheumatology, Kunming Children\u2019s Hospital (Affiliated to Kunming Medical University), Kunming, Yunnan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260413","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/138920291501140306113715","article-title":"Systemic lupus erythematosus: old and new susceptibility genes versus clinical manifestations.","volume":"15","author":"De Azevedo Silva","year":"2014","journal-title":"Curr Genomics"},{"key":"R2-20260413","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00281-014-0428-6","article-title":"The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved.","volume":"36","author":"Rekvig","year":"2014","journal-title":"Semin Immunopathol"},{"key":"R3-20260413","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/cei.12439","article-title":"CXCL13 as a new biomarker of systemic lupus erythematosus and lupus nephritis - from bench to bedside?","volume":"179","author":"Schiffer","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"R4-20260413","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/annrheumdis-2016-210960","article-title":"European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative.","volume":"76","author":"Groot","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R5-20260413","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the international society of nephrology\/renal pathology society classification for lupus nephritis: clarification of definitions, and modified national institutes of health activity and chronicity indices.","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int"},{"key":"R6-20260413","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/art.34426","article-title":"Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis.","volume":"64","author":"Brunner","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R7-20260413","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1093\/rheumatology\/keab126","article-title":"Early predictors of renal outcome in patients with proliferative lupus nephritis: a 36-month cohort study.","volume":"60","author":"Lu\u00eds","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R8-20260413","doi-asserted-by":"crossref","first-page":"109900","DOI":"10.1016\/j.intimp.2023.109900","article-title":"Identification of biomarkers that predict renal flare in childhood-onset lupus nephritis with mycophenolate acid.","volume":"117","author":"Li","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"R9-20260413","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.bjc.6601118","article-title":"Survival analysis part I: basic concepts and first analyses.","volume":"89","author":"Clark","year":"2003","journal-title":"Br J Cancer"},{"key":"R10-20260413","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1002\/art.20666","article-title":"Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-lupus nephritis trial.","volume":"50","author":"Houssiau","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R11-20260413","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases.","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney International"},{"key":"R12-20260413","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European league against rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus.","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R13-20260413","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/1759720X13485503","article-title":"Biomarkers in systemic lupus erythematosus: challenges and prospects for the future.","volume":"5","author":"Liu","year":"2013","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"R14-20260413","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/CIRCRESAHA.108.190611","article-title":"Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques.","volume":"105","author":"Eisenhardt","year":"2009","journal-title":"Circ Res"},{"key":"R15-20260413","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus.","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R16-20260413","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13293-019-0274-2","article-title":"Sex differences in clinical presentation of systemic lupus erythematosus.","volume":"10","author":"Ram\u00edrez Sep\u00falveda","year":"2019","journal-title":"Biol Sex Differ"},{"key":"R17-20260413","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/1574887112666171123113200","article-title":"Lupus nephritis: current treatment paradigm and unmet needs.","volume":"13","author":"Menez","year":"2018","journal-title":"Rev Recent Clin Trials"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T16:01:51Z","timestamp":1776096111000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047593","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"2025-09-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}